NOS1 and melanoma: The distinct effects of IFN-α and IFN-γ on regulating nNOS-NO signaling may help to explain the distinct clinical responses of the two isotype IFNs in melanoma patients, which also provides new insight into the pathogenesis of IFN-γ-stimulated melanoma progression.